Cite
HARVARD Citation
He, X. et al. (2018). Humanization of fibroblast growth factor 1 single‐chain antibody and validation for its antitumorigenic efficacy in breast cancer and glioma cells. Journal of cellular and molecular medicine. 22 (6), pp. 3259-3263. [Online].